Advanced search
Publication Cover
Expert Review of Clinical Immunology Volume 17, 2021 - Issue 5
Submit an article Journal homepage
3,961
Views
11
CrossRef citations to date
0
Altmetric
Editorial

Glucocorticoids in rheumatoid arthritis still on first line: the reasons

Maurizio CutoloLaboratory of Experimental Rheumatology and Academic Division of Clinical Rheumatology, Department of Internal Medicine and Specialties, University of Genova, IRCCS San Martino Polyclinic, Genova, ItalyCorrespondence[email protected]
View further author information
,
Sabrina PaolinoLaboratory of Experimental Rheumatology and Academic Division of Clinical Rheumatology, Department of Internal Medicine and Specialties, University of Genova, IRCCS San Martino Polyclinic, Genova, ItalyView further author information
&
Emanuele GotelliLaboratory of Experimental Rheumatology and Academic Division of Clinical Rheumatology, Department of Internal Medicine and Specialties, University of Genova, IRCCS San Martino Polyclinic, Genova, ItalyView further author information
Pages 417-420 | Received 14 Feb 2021, Accepted 11 Mar 2021, Published online: 19 Mar 2021

Citations (11)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Yanyan Zhang, Zhaoju Gao, Shushu Chao, Wenjuan Lu & Pingping Zhang. (2022) Transdermal delivery of inflammatory factors regulated drugs for rheumatoid arthritis. Drug Delivery 29:1, pages 1934-1950.
Read now
Eleftherios Pelechas & Alexandros A. Drosos. (2022) State-of-the-art glucocorticoid-targeted drug therapies for the treatment of rheumatoid arthritis. Expert Opinion on Pharmacotherapy 23:6, pages 703-711.
Read now

Articles from other publishers (9)

Genesee J. Martinez, Malik Appleton, Zachary A. Kipp, Analia S. Loria, Booki Min & Terry D. HindsJr.Jr.. (2024) Glucocorticoids, their uses, sexual dimorphisms, and diseases: new concepts, mechanisms, and discoveries. Physiological Reviews 104:1, pages 473-532.
Crossref
Maurizio Cutolo, Yehuda Shoenfeld, Dimitrios P. Bogdanos, Emanuele Gotelli, Mariangela Salvato, Lilla Gunkl-Tóth & György Nagy. (2023) To treat or not to treat rheumatoid arthritis with glucocorticoids? A reheated debate. Autoimmunity Reviews, pages 103437.
Crossref
Elvis Hysa, Tamara Vojinovic, Emanuele Gotelli, Elisa Alessandri, Carmen Pizzorni, Sabrina Paolino, Alberto Sulli, Vanessa Smith & Maurizio Cutolo. (2023) The dichotomy of glucocorticosteroid treatment in immuneinflammatory rheumatic diseases: an evidence-based perspective and insights from clinical practice. Rheumatology 61:4, pages 283-293.
Crossref
Pengfei Wen, Tao Ma, Binfei Zhang, Linjie Hao, Yakang Wang, Jianbin Guo, Wei Song, Jun Wang & Yumin Zhang. (2022) Identifying hub circadian rhythm biomarkers and immune cell infiltration in rheumatoid arthritis. Frontiers in Immunology 13.
Crossref
Gina Manda, Elena Milanesi, Sermin Genc, Cristina Mariana Niculite, Ionela Victoria Neagoe, Bora Tastan, Elena Mihaela Dragnea & Antonio Cuadrado. (2022) Pros and cons of NRF2 activation as adjunctive therapy in rheumatoid arthritis. Free Radical Biology and Medicine 190, pages 179-201.
Crossref
Martina Skácelová, Lucie Nekvindová, Heřman Mann, Jakub Závada, Zlatuše Křístková, Jiří Vencovský, Karel Pavelka & Pavel Horák. (2022) The beneficial effect of csDMARDs co-medication on drug persistence of first-line TNF inhibitor in rheumatoid arthritis patients: data from Czech ATTRA registry. Rheumatology International 42:5, pages 803-814.
Crossref
Hanghang Fang, Yongjie Sha, Liang Yang, Jingjing Jiang, Lichen Yin, Jiaying Li, Bin Li, Bert Klumperman, Zhiyuan Zhong & Fenghua Meng. (2022) Macrophage-Targeted Hydroxychloroquine Nanotherapeutics for Rheumatoid Arthritis Therapy. ACS Applied Materials & Interfaces 14:7, pages 8824-8837.
Crossref
Maria G. Filippa, Maria G. Tektonidou, Aimilia Mantzou, Gregory A. Kaltsas, George P. Chrousos, Petros P. Sfikakis & Maria P. Yavropoulou. (2021) Adrenocortical dysfunction in rheumatoid arthritis: Α narrative review and future directions. European Journal of Clinical Investigation 52:1.
Crossref
Maurizio Cutolo, Stefano Soldano, Emanuele Gotelli, Paola Montagna, Rosanna Campitiello, Sabrina Paolino, Carmen Pizzorni, Alberto Sulli, Vanessa Smith & Samuele Tardito. (2021) CTLA4-Ig treatment induces M1–M2 shift in cultured monocyte-derived macrophages from healthy subjects and rheumatoid arthritis patients. Arthritis Research & Therapy 23:1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.